BioXcel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.About BTAI
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions.
CEOVimal D. Mehta
CEOVimal D. Mehta
Employees37
Employees37
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2017
Founded2017
Employees37
Employees37
BTAI Key Statistics
Market cap41.99M
Market cap41.99M
Price-Earnings ratio-0.20
Price-Earnings ratio-0.20
Dividend yield—
Dividend yield—
Average volume695.74K
Average volume695.74K
High today$1.92
High today$1.92
Low today$1.72
Low today$1.72
Open price$1.75
Open price$1.75
Volume362.31K
Volume362.31K
52 Week high$9.26
52 Week high$9.26
52 Week low$1.17
52 Week low$1.17
Stock Snapshot
The current BioXcel Therapeutics(BTAI) stock price is $1.89, with a market capitalization of 41.99M. The stock trades at a price-to-earnings (P/E) ratio of -0.20.
During the trading session on 2025-11-23, BioXcel Therapeutics(BTAI) shares reached a daily high of $1.92 and a low of $1.72. At a current price of $1.89, the stock is +9.9% higher than the low and still -1.6% under the high.
Trading activity shows a volume of 362.31K, compared to an average daily volume of 695.74K.
Over the past 52 weeks, BioXcel Therapeutics(BTAI) stock has traded between a high of $9.26 and a low of $1.17.
Over the past 52 weeks, BioXcel Therapeutics(BTAI) stock has traded between a high of $9.26 and a low of $1.17.
People also own
Based on the portfolios of people who own BTAI. This list is generated using Robinhood data, and it’s not a recommendation.